Response to 'Pulmonary thrombosis in 2019-nCoV pneumonia?'
- PMID: 32291906
- PMCID: PMC7262143
- DOI: 10.1111/jth.14843
Response to 'Pulmonary thrombosis in 2019-nCoV pneumonia?'
Comment on
-
Pulmonary thrombosis in 2019-nCoV pneumonia?J Thromb Haemost. 2020 Jun;18(6):1511-1513. doi: 10.1111/jth.14818. Epub 2020 Apr 15. J Thromb Haemost. 2020. PMID: 32293083 Free PMC article. No abstract available.
References
-
- Bernard G.R., Margolis B.D., Shanies H.M., et al. Extended evaluation of recombinant human activated protein C United States Trial (ENHANCE US): a single‐arm, phase 3B, multicenter study of drotrecogin alfa (activated) in severe sepsis. Chest. 2004;125(6):2206–2216. - PubMed
-
- Taylor F.B., Toh C.H., Hoots W.K., et al. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001;86:1327–1330. - PubMed
-
- Thachil J. Platelets and infections in the resource‐limited countries with a focus on malaria and viral haemorrhagic fevers. Br J Haematol. 2017;177(6):960–970. - PubMed
-
- Gupta N., Zhao Y.Y., Evans C.E. The stimulation of thrombosis by hypoxia. Thromb Res. 2019;181:77–83. - PubMed
-
- Dalainas I. Pathogenesis, diagnosis, and management of disseminated intravascular coagulation: a literature review. Eur Rev Med Pharmacol Sci. 2008;12(1):19–31. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical